Overview

Metformin Treatment in Progressive Multiple Sclerosis

Status:
Not yet recruiting
Trial end date:
2025-05-26
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety of metformin for treatment of progressive multiple sclerosis
Phase:
Early Phase 1
Details
Lead Sponsor:
University of California, Los Angeles
Treatments:
Metformin